Overview

Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.

Status:
NOT_YET_RECRUITING

Trial end date:
2026-03-31

Target enrollment:

Participant gender:

Summary

This phase 2 study aim to investigate the effect of dobutamine in patients with sepsis/ septic shock after fluid resuscitation and with hypoperfusion (lactate and central venous oxygen saturation or prolonged capillary refill time) on renal function as compared with usual care.

Phase:

PHASE2

Details

Lead Sponsor:

Federal University of São Paulo

Treatments:

Dobutamine